Serengen synthesises and screens DNA-Encoded Libraries (DEL) tailored to your project.
Our proprietary technology offers the fastest and most cost-efficient approach to hit identification that allows for serendipity and delivers high quality hits.
Accelerate early drug discovery
Perform today’s fastest and most economical hit identification and significantly speed up early drug discovery:
Access a unique DEL technology that allows to add a truly novel chemical space to your DEL screening decks.
Benefit from serendipity in hit ID with a breakthrough DEL technology that offers lower hit attrition and lower follow-up costs.
START-UPS & RESEARCH ORGANISATIONS
Save time and budget by screening DELs that are designed for your target proteins.
Satz et al. elaborate current status of DNA-encoded chemical library (DECL) technology.
I agree that the information I supply will be processed in accordance with the General Data Protection Regulation (EU) 2016/679.